EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Alkermes Moving to Waltham

Alkermes, the Cambridge, MA-based developer of anti-addiction drugs, said today it has signed a lease to move its headquarters to Waltham, MA. The company (NASDAQ: ALKS), which has more than 600 employees, plans to complete the move in early 2010. The move is supposed to save the company $8 million a year starting in fiscal 2011.